This SuperSeries is composed of the SubSeries listed below.
Overall design: Refer to individual Series
| Accession | PRJNA163313; GEO: GSE37792 |
| Type | Umbrella project |
| Publications | Rounbehler RJ et al., "Tristetraprolin impairs myc-induced lymphoma and abolishes the malignant state.", Cell, 2012 Aug 3;150(3):563-74 |
| Submission | Registration date: 2-Aug-2012
H. Lee Moffitt Cancer Center |
| Relevance | Superseries |
Project Data:
| Resource Name | Number
of Links |
|---|
| Publications |
| PubMed | 1 |
| PMC | 1 |
| Other datasets |
| GEO DataSets | 4 |
GEO Data Details| Parameter | Value |
|---|
| Data volume, Spots | 1216767 |
| Data volume, Processed Mbytes | 26 |
| Data volume, Supplementary Mbytes | 101 |
Tristetraprolin is a tumor suppressor that impairs Myc-induced lymphoma and abolishes the malignant state encompasses the following 3 sub-projects:
| Project Type | Number of Projects |
| Transcriptome or Gene expression | 3 |
BioProject
accession | Organism | Title |
|---|
| PRJNA148759 | Mus musculus | Tristetraprolin is a tumor suppressor that impairs Myc-induced lymphoma and abolishes the malignant state [bone marrow B cells]. (H. Lee Moffitt Cancer Center) | | PRJNA163335 | Mus musculus | Tristetraprolin is a tumor suppressor that impairs Myc-induced lymphoma and abolishes the malignant state [Lymphoma]. (H. Lee Moffitt Cancer Center) | | PRJNA163337 | Mus musculus | Tristetraprolin is a tumor suppressor that impairs Myc-induced lymphoma and abolishes the malignant state [retrovirally infected ex vivo lymphoma] (H. Lee Moffitt Cancer Center) |
|